Research & Development



  雲瑯驚恐的瞅著阿嬌低聲道︰“我們在談生意,談的好好地,你為什麼會說這麼奇怪的話題?我如果帶你走,你信不信陛下會把這天下翻個遍,把我們捉出來,然後再把我們剁成狗肉醬喂狗?”   果然,雲瑯熟悉的箭雨呼嘯聲在頭頂響起,然後就是密集的雨打芭蕉之音……免费网站看AV片   “這個孽子在干什麼?”人人超碰xxoo免费视频   雲瑯跟曹襄離開了農田,施施然的走進了陽陵邑。   原本應該保護皇帝的護衛們,早就死光了。av视频在线观看免费观   劉據笑道︰“我昔日跟雲瑯學農事,身上沾滿了肥料的臭味,母親也從未嫌棄過,怎麼,現在一點酒氣母親就受不了了?”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo